Advita Ortho Reports First Clinical Use of Activit-E® Humeral Liners
Plantation, Florida, USA — July 24, 2026 Advita Ortho has announced the first clinical use of Equinoxe® Reverse Shoulder...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Plantation, Florida, USA — July 24, 2026 Advita Ortho has announced the first clinical use of Equinoxe® Reverse Shoulder...
TOKOROZAWA, Japan, June 30, 2026 Advita Ortho announced the first clinical use of its next-generation knee replacement platform in...
